• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

COVID-19 Vaccine Performance: What’s Currently Known?

Slideshow

The US Centers for Disease Control and Prevention recently updated its science brief on COVID-19 vaccines currently authorized for emergency use (Pfizer-BioNTech, Moderna, and Johnson & Johnson), in which the agency synthesized the latest clinical trial data available through July 24, 2021. Data were added on vaccine efficacy and effectiveness against SARS-CoV-2 infection and SARS-CoV-2 variants, including the now dominant Delta variant. In the slides below, we summarize the key takeaways for primary care.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
Related Content
Shingrix Nearly 80% Effective Against Shingles in Older Adults up to 11 Years Post-Vaccination / Image credit: ©Sherry Young/AdobeStock

Shingrix Nearly 80% Effective Against Shingles in Older Adults up to 11 Years Post-Vaccination

April 18th 2024
Article

Vaccine efficacy remained high at 82% at year 11 following vaccination, according to new long-term data.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine / image credit GSK vaccines: ©desertsands/stock.adobe.com

GSK Announces FDA PDUFA Date for 5-in-1 Meningococcal Vaccine Based on Acceptance of BLA

April 17th 2024
Article

The FDA expects to take action on the GSK BLA for its pentavalent MenB vaccine by February 14, 2025.

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns

October 25th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.

Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study / Image credit: ©Tsuboya/AdobeStock

Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study

March 29th 2024
Article

Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose / image credit: ©New Africa/AdobeStock

COVID-19 Vaccines Reduce Risk of Cardiac, Thromboembolic Outcomes: Daily Dose

March 27th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.